bf/NASDAQ:NKTR_icon.jpeg

COM:NEKTAR

Nektar Therapeutics

  • Stock

Last Close

1.01

22/11 21:00

Market Cap

244.75M

Beta: -

Volume Today

4.63M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
15.86M
-
13.20M
16.76%
12.15M
7.98%
11.23M
7.58%
10.92M
2.76%
11.05M
1.25%
12.02M
8.77%
13.98M
16.26%
15.55M
11.22%
17.50M
12.58%
17.65M
0.86%
average payables
5.99M
-
5.91M
1.34%
2.53M
57.13%
2.59M
2.23%
3.80M
46.71%
5.32M
39.98%
12.54M
135.88%
20.69M
64.91%
15.94M
22.93%
11.36M
28.72%
11.41M
0.44%
average receivables
4.02M
-
2.92M
27.36%
11.78M
303.60%
17.81M
51.25%
10.35M
41.92%
24.11M
133.07%
40.01M
65.91%
37.85M
5.40%
30.69M
18.91%
14.24M
53.61%
3.59M
74.76%
book value per share
-0.78
-
0.29
136.86%
0.05
83.05%
0.63
1,200.65%
0.56
10.79%
10.13
1,698.25%
8.03
20.70%
6.03
24.89%
3.71
38.55%
1.96
47.15%
0.69
64.81%
capex per share
-0.04
-
-0.08
122.44%
-0.08
7.49%
-0.05
45.82%
-0.06
35.50%
-0.08
35.32%
-0.15
78.91%
-0.04
72.94%
-0.08
101.20%
-0.03
62.91%
-0.00
84.99%
capex to depreciation
-0.29
-
-0.77
169.28%
-0.87
12.85%
-0.42
52.19%
-0.66
57.64%
-1.31
99.56%
-2.00
52.52%
-0.51
74.38%
-1.06
107.04%
-0.44
58.89%
0.12
128.20%
capex to operating cash flow
0.11
-
0.07
33.84%
0.15
118.05%
0.05
64.34%
0.12
120.29%
-0.02
116.48%
0.08
503.37%
0.02
71.03%
0.04
56.79%
0.02
48.60%
0.00
75.95%
capex to revenue
-0.03
-
-0.05
80.93%
-0.05
2.41%
-0.04
20.35%
-0.03
18.61%
-0.01
62.05%
-0.23
1,821.93%
-0.05
79.30%
-0.15
209.89%
-0.06
58.08%
-0.01
84.43%
cash per share
2.05
-
1.87
8.47%
2.33
24.43%
2.79
19.51%
1.90
31.88%
7.87
314.65%
7.57
3.84%
5.95
21.46%
4.00
32.66%
2.70
32.61%
1.60
40.78%
days of inventory on hand
127.50
-
165.68
29.95%
121.44
26.71%
134.20
10.51%
128.16
4.50%
170.16
32.77%
216.28
27.10%
286.57
32.50%
231.65
19.17%
323.95
39.85%
days payables outstanding
86.39
-
34.58
59.98%
25.29
26.85%
34.02
34.50%
57.14
67.97%
87.53
53.18%
328.46
275.26%
414.89
26.31%
142.89
65.56%
218.98
53.25%
days sales outstanding
5.46
-
6.56
20.07%
31.55
380.94%
34.59
9.64%
5.95
82.81%
13.22
122.24%
117.20
786.68%
92.83
20.79%
80.56
13.21%
23.71
70.56%
4.88
79.42%
debt to assets
0.41
-
0.30
25.86%
0.49
63.18%
0.44
11.51%
0.54
24.65%
0.14
73.64%
0.20
42.28%
0.10
52.19%
0.13
31.22%
0.19
44.39%
0.30
59.90%
debt to equity
-1.97
-
3.68
286.46%
38.57
948.40%
2.82
92.69%
3.16
11.88%
0.18
94.31%
0.29
59.91%
0.14
51.46%
0.21
51.04%
0.36
70.21%
0.90
150.70%
dividend yield
earnings yield
-0.12
-
-0.03
77.77%
-0.04
32.66%
-0.09
146.44%
-0.01
88.42%
0.12
1,277.18%
-0.12
195.44%
-0.15
25.51%
-0.21
44.50%
-0.87
311.56%
-2.57
195.38%
enterprise value
1.41B
-
2.09B
48.33%
2.42B
16.12%
1.90B
21.55%
9.55B
402.36%
5.63B
41.11%
4.09B
27.39%
2.99B
26.89%
2.59B
13.15%
466.20M
82.03%
189.85M
59.28%
enterprise value over ebitda
-13.44
-
-760.87
5,561.39%
-163.41
78.52%
-19.99
87.76%
-391.56
1,858.34%
7.64
101.95%
-10.74
240.51%
-8.60
19.92%
-5.72
33.50%
-2.11
63.02%
-0.72
65.94%
ev to operating cash flow
-36.53
-
-14.70
59.76%
-33.17
125.62%
-16.25
51.01%
-118.81
631.08%
7.83
106.59%
-12.43
258.67%
-9.54
23.29%
-6.29
34.07%
-1.53
75.61%
-0.99
35.72%
ev to sales
9.45
-
10.40
10.06%
10.50
0.98%
11.50
9.43%
31.05
170.09%
4.72
84.81%
35.65
655.98%
19.54
45.20%
25.46
30.32%
5.06
80.11%
2.11
58.40%
free cash flow per share
-0.37
-
-1.20
225.30%
-0.64
46.89%
-0.88
38.95%
-0.58
34.66%
4.15
818.54%
-2.03
148.87%
-1.79
11.51%
-2.33
29.98%
-1.65
29.07%
-1.02
38.47%
free cash flow yield
-0.03
-
-0.08
138.20%
-0.04
51.14%
-0.07
90.82%
-0.01
86.58%
0.13
1,405.48%
-0.09
174.40%
-0.11
12.38%
-0.17
63.56%
-0.73
324.01%
-1.80
146.13%
graham net net
-2.41
-
-1.25
48.25%
-1.25
0.49%
-0.53
57.53%
-0.74
39.43%
5.55
847.22%
4.50
18.95%
3.57
20.64%
1.75
50.92%
0.94
46.58%
0.24
74.39%
graham number
4.95
-
1.65
66.55%
0.82
50.56%
3.95
383.12%
2.80
29.08%
30.25
979.41%
21.33
29.49%
18.38
13.84%
15.44
16.00%
9.31
39.68%
4.75
49.02%
income quality
0.24
-
2.63
1,007.58%
0.90
65.82%
0.76
15.33%
0.83
9.10%
1.05
26.76%
0.75
29.25%
0.70
5.49%
0.79
11.76%
0.83
4.81%
0.70
15.50%
intangibles to total assets
0.18
-
0.17
1.61%
0.15
12.04%
0.13
11.74%
0.15
11.79%
0.04
76.33%
0.04
8.74%
0.05
28.50%
0.07
37.74%
0.11
57.22%
0
100%
interest coverage
-2.95
-
-0.43
85.57%
-0.76
77.51%
-2.68
254.37%
-1.46
45.57%
16.08
1,204.25%
-9.49
159.03%
-10.24
7.82%
-9.43
7.88%
-8.31
11.87%
10.41
225.26%
interest debt per share
1.88
-
1.36
27.90%
2.17
59.36%
2.08
3.81%
2.04
2.06%
2.07
1.59%
2.57
24.16%
1.05
59.22%
1.04
0.97%
0.86
17.52%
0.49
43.24%
inventory turnover
2.86
-
2.20
23.05%
3.01
36.44%
2.72
9.51%
2.85
4.71%
2.14
24.68%
1.69
21.32%
1.27
24.53%
1.58
23.71%
1.13
28.49%
invested capital
-1.97
-
3.68
286.46%
38.57
948.40%
2.82
92.69%
3.16
11.88%
0.18
94.31%
0.29
59.91%
0.14
51.46%
0.21
51.04%
0.36
70.21%
0.90
150.70%
market cap
1.31B
-
1.97B
49.71%
2.23B
13.50%
1.71B
23.26%
9.31B
443.75%
5.57B
40.14%
3.78B
32.23%
3.04B
19.65%
2.48B
18.43%
422.93M
82.92%
107.35M
74.62%
net current asset value
-266.55M
-
-117.09M
56.07%
-145.58M
24.33%
-54.49M
62.57%
-94.22M
72.90%
1.01B
1,166.77%
849.59M
15.47%
676.53M
20.37%
357.90M
47.10%
202.01M
43.56%
63.66M
68.49%
net debt to ebitda
-0.90
-
-44.20
4,825.58%
-12.97
70.66%
-1.99
84.68%
-9.85
396.05%
0.07
100.72%
-0.81
1,243.58%
0.14
117.33%
-0.26
285.58%
-0.20
24.52%
-0.31
59.47%
net income per share
-1.40
-
-0.42
69.64%
-0.61
44.21%
-1.10
79.45%
-0.62
43.62%
4.02
747.92%
-2.52
162.69%
-2.49
1.17%
-2.86
14.83%
-1.97
31.15%
-1.45
26.15%
operating cash flow per share
-0.33
-
-1.12
236.22%
-0.55
50.71%
-0.84
51.94%
-0.52
38.49%
4.23
921.28%
-1.88
144.35%
-1.75
6.60%
-2.25
28.33%
-1.62
27.84%
-1.01
37.60%
payables turnover
4.22
-
10.56
149.86%
14.43
36.71%
10.73
25.65%
6.39
40.47%
4.17
34.72%
1.11
73.35%
0.88
20.83%
2.55
190.34%
1.67
34.75%
receivables turnover
66.81
-
55.64
16.71%
11.57
79.21%
10.55
8.80%
61.37
481.59%
27.61
55.00%
3.11
88.72%
3.93
26.25%
4.53
15.23%
15.39
239.70%
74.79
385.93%
research and ddevelopement to revenue
1.28
-
0.74
42.31%
0.79
7.60%
1.23
55.54%
0.87
29.18%
0.33
61.62%
3.79
1,032.42%
2.67
29.51%
3.93
46.97%
2.37
39.62%
1.27
46.59%
return on tangible assets
-0.45
-
-0.15
67.37%
-0.19
29.18%
-0.31
63.46%
-0.22
28.28%
0.33
246.92%
-0.23
170.56%
-0.30
31.11%
-0.50
65.61%
-0.58
15.36%
-0.69
19.44%
revenue per share
1.29
-
1.58
22.94%
1.74
10.14%
1.19
31.98%
1.97
66.49%
7.04
256.60%
0.65
90.69%
0.86
30.73%
0.56
35.07%
0.49
11.52%
0.47
3.58%
roe
1.80
-
-1.48
182.35%
-12.63
750.87%
-1.74
86.20%
-1.10
36.81%
0.40
136.03%
-0.31
179.05%
-0.41
31.57%
-0.77
86.86%
-1.00
30.27%
-2.11
109.86%
roic
-1.28
-
-0.09
92.83%
-0.11
24.25%
-0.33
192.31%
-0.16
50.47%
0.34
306.03%
-0.22
166.20%
-0.28
23.07%
-0.46
67.50%
-0.38
16.75%
-0.72
86.76%
sales general and administrative to revenue
0.27
-
0.20
25.08%
0.19
8.06%
0.27
42.75%
0.17
36.41%
0.07
59.89%
0.86
1,161.90%
0.68
20.51%
1.21
76.09%
1.00
16.79%
0.86
14.36%
shareholders equity per share
-0.78
-
0.29
136.86%
0.05
83.05%
0.63
1,200.65%
0.56
10.79%
10.13
1,698.25%
8.03
20.70%
6.03
24.89%
3.71
38.55%
1.96
47.15%
0.69
64.81%
stock based compensation to revenue
0.12
-
0.08
28.70%
0.09
0.52%
0.16
83.34%
0.12
23.85%
0.07
37.95%
0.87
1,079.33%
0.62
29.20%
0.93
50.71%
0.62
32.98%
0.37
40.50%
tangible asset value
-166.40M
-
-40.17M
75.86%
-70.07M
74.44%
11.62M
116.59%
11.33M
2.56%
1.64B
14,388.16%
1.33B
19.02%
1.00B
24.69%
603.01M
39.75%
290.14M
51.88%
130.99M
54.85%
tangible book value per share
-1.44
-
-0.32
77.98%
-0.53
67.09%
0.08
115.74%
0.07
12.78%
9.68
13,222.36%
7.59
21.52%
5.60
26.20%
3.29
41.30%
1.55
52.87%
0.69
55.53%
working capital
159.66M
-
224.15M
40.39%
288.81M
28.84%
354.03M
22.58%
270.66M
23.55%
1.36B
400.89%
1.07B
21.25%
1.02B
4.26%
710.38M
30.51%
477.76M
32.75%
279.43M
41.51%

All numbers in (except ratios and percentages)